AlphaYouDMRA: Jarrett Jennifer discloses a purchase
By AlphaYouPublished Form 4
Jarrett Jennifer
Reporting filer
Jarrett Jennifer reported Purchase in Damora Therapeutics, Inc.: 12500 units of Ordinary Shares, dated 2026-09-25. The full Form 4 contains 1 transaction entry.
- Disclosed
- Sep 28, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jarrett Jennifer | 2026-09-25 | P | Purchase | 12500 | 20.23 | 512,500 | 3 days | Filed terms
|
Ordinary Shares
- Owner
- Jarrett Jennifer
- Date
- 2026-09-25
- Code
- P
- Action
- Purchase
- Quantity
- 12500
- Price
- 20.23
- Following holdings
- 512,500
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Ordinary Shares
- transaction Date: 2026-09-25
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: false
- id: F1
- transaction Shares: 12500
- transaction Price Per Share: 20.23
- id: F2
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 512500
- id: F3
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Jarrett Jennifer: Director, President and CEO, Director.
- F1: Represents shares purchased on the open market at prevailing market prices using personal funds.
- F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $20.10 to $20.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- F3: Includes 500,000 restricted stock units ("RSUs") previously granted to the Reporting Person. Each RSU represents the right to receive, at settlement, one ordinary share of the Issuer.
Original sources
Prepared automatically from public filing data. Report a correction.